Mersana Therapeutics Price to Book Ratio 2016-2021 | MRSN
For a detailed definition, formula and example for Price/Book Ratio, check out our new background page here.
Historical price to book ratio values for Mersana Therapeutics (MRSN) over the last 10 years. The current price to book ratio for Mersana Therapeutics as of October 15, 2021 is 3.02.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Mersana Therapeutics Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2021-10-15 |
8.49 |
|
3.10 |
| 2021-06-30 |
13.58 |
$2.74 |
4.96 |
| 2021-03-31 |
16.18 |
$2.87 |
5.64 |
| 2020-12-31 |
26.61 |
$3.31 |
8.03 |
| 2020-09-30 |
18.62 |
$3.70 |
5.03 |
| 2020-06-30 |
23.40 |
$4.00 |
5.85 |
| 2020-03-31 |
5.83 |
$1.31 |
4.44 |
| 2019-12-31 |
5.73 |
$1.73 |
3.32 |
| 2019-09-30 |
1.58 |
$1.94 |
0.81 |
| 2019-06-30 |
4.05 |
$2.27 |
1.78 |
| 2019-03-31 |
5.26 |
$2.60 |
2.02 |
| 2018-12-31 |
4.08 |
$0.38 |
10.78 |
| 2018-09-30 |
10.00 |
$1.29 |
7.76 |
| 2018-06-30 |
17.86 |
$1.98 |
9.04 |
| 2018-03-31 |
15.77 |
$2.47 |
6.38 |
| 2017-12-31 |
16.43 |
$3.07 |
5.34 |
| 2017-09-30 |
17.29 |
$3.68 |
4.70 |
| 2017-06-30 |
13.97 |
$15.29 |
0.91 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.609B |
$0.001B |
|
Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.
|
